Keywords: valeant, deal, buy, coria, labs, california-based, pharmaceuticals
Valeant in deal to buy Coria Labs
Article | 29 September 2008
California-based Valeant Pharmaceuticals International, which recently sold some of its eastern European/Russian businesses to Sweden's Meda for $392.0 million (Marketletter ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
